Calyxt, Inc. (CLXT)
| Market Cap | 93.57M |
| Revenue (ttm) | 37.97M |
| Net Income (ttm) | -35.54M |
| Shares Out | 38.51M |
| EPS (ttm) | -0.96 |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 218,473 |
| Open | 2.48 |
| Previous Close | 2.49 |
| Day's Range | 2.43 - 2.59 |
| 52-Week Range | 2.18 - 12.43 |
| Beta | 1.84 |
| Analysts | Buy |
| Price Target | 7.63 (+214.0%) |
| Earnings Date | Nov 4, 2021 |
About CLXT
Calyxt, Inc., a technology company, focuses on delivering plant-based solutions in the United States. It engages in the development of improved digestibility alfalfa; high fiber wheat; high oleic low linolenic soybeans; winter oats; hemp; fat soybeans; and cold storable potatoes. As of March 4, 2021, the company had nine projects at Phase I stage or later in development across alfalfa, hemp, oats, soybeans, and wheat. Calyxt, Inc. has a research collaboration with NRGene, which includes the adoption of NRGene's cloud-based genomics platform to ...
Financial Performance
Financial StatementsAnalyst Forecast
According to 7 analysts, the average rating for Calyxt stock is "Buy." The 12-month stock price forecast is 7.63, which is an increase of 213.99% from the latest price.
News
Calyxt Identifies More Than 15,000 Unique Chemical Signatures in Lab-Scale BioFactory™ Production Run
ROSEVILLE, Minn., Dec. 8, 2021 /PRNewswire/ -- Calyxt, Inc. (Nasdaq: CLXT), a plant-based synthetic biotechnology company, today announced the completion of a key milestone in its lab-scale BioFactory™...
Calyxt Announces Strategic Hires in AI/ML and Technology Licensing
ROSEVILLE, Minn., Dec. 6, 2021 /PRNewswire/ -- Calyxt, Inc. (Nasdaq: CLXT), a plant-based synthetic biotechnology company, today announced the hiring of two senior roles important to furthering Calyxt...
Calyxt to Present at the 2021 Canaccord Genuity AgriFood Tech Innovation Virtual Forum
ROSEVILLE, Minn., Nov. 23, 2021 /PRNewswire/ -- Calyxt, Inc. (Nasdaq: CLXT), a plant-based synthetic biotechnology company, today announced that management will present at the 2021 Canaccord Genuity A...
Calyxt (CLXT) Reports Q3 Loss, Tops Revenue Estimates
Calyxt (CLXT) delivered earnings and revenue surprises of -26.32% and 69.48%, respectively, for the quarter ended September 2021. Do the numbers hold clues to what lies ahead for the stock?
Calyxt Reports Third Quarter 2021 Financial Results
ROSEVILLE, Minn., Nov. 4, 2021 /PRNewswire/ -- Calyxt, Inc. (NASDAQ: CLXT), a plant-based synthetic biotechnology company, today announced financial results for its third quarter ended September 30, 2...
5 Penny Stocks To Buy According To Analysts & Price Targets Up To 175%
Some of the best penny stocks 2021 has offered were some of… The post 5 Penny Stocks To Buy According To Analysts & Price Targets Up To 175% appeared first on Penny Stocks to Buy, Picks, News and Inform...
Will Calyxt (CLXT) Report Negative Earnings Next Week? What You Should Know
Calyxt (CLXT) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Calyxt to Host third Quarter 2021 Financial Results Conference Call on Thursday, November 4, 2021, at 4:30 p.m. Easte...
ROSEVILLE, Minn., Oct. 19, 2021 /PRNewswire/ -- Calyxt, Inc. (Nasdaq: CLXT) will hold a conference call on Thursday, November 4, 2021, at 4:30 p.m.
Calyxt Names IBM's Global Chief Artificial Intelligence Officer, Dr. Seth Dobrin, to Scientific Advisory Board
ROSEVILLE, Minn., Oct. 12, 2021 /PRNewswire/ -- Calyxt, Inc. (Nasdaq: CLXT), a plant-based synthetic biotechnology company, today announced the appointment of Seth Dobrin, Ph.D.
Calyxt Announces New Strategic Direction to Provide Sustainable, Plant-Based Synthetic Biology Solutions to Expanded ...
ROSEVILLE, Minn., Oct. 5, 2021 /PRNewswire/ -- Calyxt, Inc. (Nasdaq: CLXT), a plant-based synthetic biotechnology company, today announced the launch of a strategic initiative that will focus the Comp...
Calyxt Seeks To Develop Palm Oil Alternative
Calyxt Inc (NASDAQ: CLXT) has entered into a research collaboration with a food ingredient manufacturer based in Asia to develop an improved soybean to produce oil as a commercial alternative to palm oi...
Calyxt Announces Collaboration with Leading Global Food Ingredient Manufacturer to Develop Palm Oil Alternative
ROSEVILLE, Minn., Sept. 28, 2021 /PRNewswire/ -- Calyxt, Inc. (Nasdaq: CLXT), a plant-based technology platform company, today announced it entered into a research collaboration with a leading global ...
Calyxt to Present at the H.C Wainwright 23rd Annual Global Investment Conference
ROSEVILLE, Minn., Sept. 7, 2021 /PRNewswire/ -- Calyxt, Inc. (NASDAQ: CLXT), a plant-based technology platform company, today announced that a presentation given by management at the H.C Wainwright 23rd...
5 Penny Stocks Insiders Are Buying
When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders interested in penny stocks can consider this a factor in their overa...
Calyxt (CLXT) Reports Q2 Loss, Tops Revenue Estimates
Calyxt (CLXT) delivered earnings and revenue surprises of -10.53% and 50.00%, respectively, for the quarter ended June 2021. Do the numbers hold clues to what lies ahead for the stock?
Calyxt: Q2 Earnings Insights
Shares of Calyxt (NASDAQ:CLXT) rose in after-market trading after the company reported Q2 results. Quarterly Results Earnings per share were up 36.36% over the past year to ($0.21), which missed the est...
Calyxt Reports Second Quarter 2021 Financial Results
ROSEVILLE, Minn., Aug. 5, 2021 /PRNewswire/ -- Calyxt, Inc. (NASDAQ: CLXT), a plant-based technology company, today announced financial results for its second quarter ended June 30, 2021.
Calyxt to Present at the Canaccord Genuity 41st Annual Growth Conference on August 11, 2021
ROSEVILLE, Minn., Aug. 4, 2021 /PRNewswire/ -- Calyxt, Inc. (Nasdaq: CLXT), a plant-based biotechnology platform company, today announced that management will present at the Canaccord Genuity 41st Ann...
Calyxt (CLXT) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release
Calyxt (CLXT) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Calyxt Reports Inducement Grant Under NASDAQ Listing Rule 5635(c)(4)
ROSEVILLE, Minn., July 27, 2021 /PRNewswire/ -- Calyxt, Inc. (NASDAQ: CLXT), a plant-based biotechnology platform company, today announced that, in accordance with the offer letter entered into on July...
Calyxt to Host Second Quarter 2021 Financial Results Conference Call on Thursday, August 5, 2021 at 4:30 p.m. Eastern...
ROSEVILLE, Minn., July 19, 2021 /PRNewswire/ -- Calyxt, Inc. (NASDAQ: CLXT) will hold a conference call on Thursday, August 5, 2021 at 4:30 p.m.
Calyxt Appoints Michael A. Carr As CEO
Biotechnology company Calyxt Inc (NASDAQ: CLXT) has appointed Michael A. Carr as President and Chief Executive Officer, effective July 27, 2021.
Calyxt Appoints Michael A. Carr as Chief Executive Officer
ROSEVILLE, Minn., July 15, 2021 /PRNewswire/ -- Calyxt, Inc. (NASDAQ: CLXT), a plant-based biotechnology platform company, today announced the appointment of Michael A.
Calyxt Announces Expansion of Hemp Breeding Platform with Seedless Hemp Innovation
Triploid Breeding Process is Calyxt's Second Announced Advancement and Part of a Comprehensive Approach to Improving Hemp Genetics ROSEVILLE, MN / ACCESSWIRE / July 8, 2021 / Calyxt, Inc. (NASDAQ:CLXT),...
The Top 7 Gene-Editing Stocks to Buy for the Biggest Scientific Breakthrough of the Century
Doudna's breakthrough in CRISPR has since ushered in a new era of genetic engineering, making these the best gene-editing stocks to buy. The post The Top 7 Gene-Editing Stocks to Buy for the Biggest Sci...